APA (7th ed.) Citation

Kushlaf, H., Díaz‐Manera, J., Bratkovic, D., Byrne, B. J., Claeys, K. G., Clemens, P. R., . . . Mozaffar, T. (2025). Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL. Muscle & nerve, 72(2), 230-239. https://doi.org/10.1002/mus.28420

Chicago Style (17th ed.) Citation

Kushlaf, Hani, et al. "Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL." Muscle & Nerve 72, no. 2 (2025): 230-239. https://doi.org/10.1002/mus.28420.

MLA (9th ed.) Citation

Kushlaf, Hani, et al. "Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL." Muscle & Nerve, vol. 72, no. 2, 2025, pp. 230-239, https://doi.org/10.1002/mus.28420.